Gilder Gagnon Howe & CO LLC Abiomed Inc Transaction History

Gilder Gagnon Howe & CO LLC

$7.87 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$242.49 - $301.46 $24,249 - $30,145	100 Added 0.21%	47,316 $11.6 Million
Q2 2022 Aug 15, 2022	SELL	$224.73 - $338.64 $1.11 Million - $1.67 Million	-4,946 Reduced 9.48%	47,216 $11.7 Million
Q1 2022 May 16, 2022	SELL	$277.25 - $366.29 $31.8 Million - $42.1 Million	-114,810 Reduced 68.76%	52,162 $17.3 Million
Q4 2021 Feb 14, 2022	SELL	$300.63 - $371.35 $266,057 - $328,644	-885 Reduced 0.53%	166,972 $60 Million
Q3 2021 Nov 15, 2021	SELL	$310.19 - $376.2 $339,037 - $411,186	-1,093 Reduced 0.65%	167,857 $54.6 Million
Q2 2021 Aug 16, 2021	SELL	$262.71 - $351.17 $3 Million - $4 Million	-11,401 Reduced 6.32%	168,950 $52.7 Million
Q1 2021 May 17, 2021	BUY	$285.92 - $355.13 $15.3 Million - $19 Million	53,502 Added 42.18%	180,351 $57.5 Million
Q4 2020 Feb 16, 2021	SELL	$251.88 - $324.2 $333,741 - $429,565	-1,325 Reduced 1.03%	126,849 $41.1 Million
Q3 2020 Nov 16, 2020	SELL	$255.22 - $317.0 $489,767 - $608,323	-1,919 Reduced 1.48%	128,174 $35.5 Million
Q2 2020 Aug 14, 2020	SELL	$141.4 - $257.09 $1.08 Million - $1.96 Million	-7,638 Reduced 5.55%	130,093 $31.4 Million
Q1 2020 May 15, 2020	SELL	$130.51 - $196.01 $1.49 Million - $2.24 Million	-11,443 Reduced 7.67%	137,731 $20 Million
Q4 2019 Feb 14, 2020	BUY	$159.31 - $223.54 $46,837 - $65,720	294 Added 0.2%	149,174 $25.4 Million
Q3 2019 Nov 14, 2019	SELL	$175.89 - $279.23 $3.55 Million - $5.64 Million	-20,204 Reduced 11.95%	148,880 $26.5 Million
Q2 2019 Aug 13, 2019	SELL	$250.96 - $284.94 $12.4 Million - $14.1 Million	-49,480 Reduced 22.64%	169,084 $44 Million
Q1 2019 May 17, 2019	SELL	$276.39 - $362.25 $728,840 - $955,253	-2,637 Reduced 1.19%	218,564 $62.4 Million
Q4 2018 Feb 14, 2019	BUY	$281.08 - $444.25 $2.69 Million - $4.25 Million	9,570 Added 4.52%	221,201 $71.9 Million
Q3 2018 Oct 30, 2018	BUY	$354.53 - $449.75 $5.2 Million - $6.6 Million	14,681 Added 7.45%	211,631 $95.2 Million
Q2 2018 Jul 31, 2018	BUY	$278.07 - $446.21 $10.1 Million - $16.2 Million	36,371 Added 22.65%	196,950 $80.6 Million
Q1 2018 Apr 30, 2018	BUY	$192.49 - $295.85 $27.1 Million - $41.6 Million	140,728 Added 708.92%	160,579 $46.7 Million
Q4 2017 Jan 31, 2018	BUY	$168.78 - $199.74 $810,650 - $959,351	4,803 Added 31.92%	19,851 $3.72 Million
Q3 2017 Nov 06, 2017	BUY	$145.39 - $168.6 $2.19 Million - $2.54 Million	15,048	15,048 $2.54 Million

Others Institutions Holding ABMD

# of Institutions

Shares Held

137K

Call Options Held

Put Options Held

View Full List

About ABIOMED INC

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

More about ABMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gilder Gagnon Howe & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gilder Gagnon Howe & CO LLC with notifications on news.

Account